Axsome Therapeutics
AXSM
AXSM
260 hedge funds and large institutions have $3.09B invested in Axsome Therapeutics in 2024 Q1 according to their latest regulatory filings, with 45 funds opening new positions, 96 increasing their positions, 75 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
1.03% less ownership
Funds ownership: 82.88% → 81.84% (-1%)
25% less call options, than puts
Call options by funds: $49.5M | Put options by funds: $66.4M
31% less funds holding in top 10
Funds holding in top 10: 13 → 9 (-4)
Holders
260
Holding in Top 10
9
Calls
$49.5M
Puts
$66.4M
Top Buyers
| 1 | +$56.5M | |
| 2 | +$36.7M | |
| 3 | +$25.6M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$23.5M |
| 5 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$19M |
Top Sellers
| 1 | -$158M | |
| 2 | -$38.5M | |
| 3 | -$29.1M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$25.5M |
| 5 |
Morgan Stanley
New York
|
-$24.8M |